GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>my guess is pk modifications, like ADCC, involve modifications in glycosylation<

Right. I was hoping to get some color on whether the longer half-life is by design or by the luck of the draw. We'll presumbaly hear more when this candidate gets closer to entering the clinic.